COMBINED THERAPEUTIC USE OF DLL4 ANTAGONIST AND HYPOTENSIVE AGENT, AND TREATMENT METHOD BY THE SAME

摘要

PROBLEM TO BE SOLVED: To provide a method for treating cancer which is effective for a cancer patient who is affected with hypertension, has a risk of onset of hypertension, or for whom prevention or suppression of hypertension is desired.SOLUTION: A method for administering a DLL4 antagonist which is an antibody specifically binding to a delta-like ligand-4 (DLL4), and one or a plurality of hypotensive agents to an early-stage cancer patient.SELECTED DRAWING: None